Search

Your search keyword '"Chaplinskas S"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Chaplinskas S" Remove constraint Author: "Chaplinskas S"
48 results on '"Chaplinskas S"'

Search Results

1. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

3. Infection-related and -unrelated malignancies, HIV and the aging population

4. Tuberculosis among HIV-positive patients across Europe: changes over time and risk factors

5. Non-AIDS defining cancers in the D:A:D Study--time trends and predictors of survival: a cohort study

6. Hyaluronic acid levels predict risk of hepatic encephalopathy and liver-related death in HIV/viral hepatitis coinfected patients

7. Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study

8. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

9. Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy : not all AIDS-defining conditions are created equal

10. Development of a definition for rapid progression (RP) of renal function in HIV-positive persons:the D:A:D study

11. Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations

12. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

13. Hepatitis c virus viremia increases the Incidence of chronic kidney disease in HIV-infected Patients

14. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study

15. Estimating prevalence of accumulated HIV-1 drug resistance in a cohort of patients on antiretroviral therapy

16. A standardized algorithm for determining the underlying cause of death in HIV infection as AIDS or non-AIDS related: results from the EuroSIDA study

17. A comparison of the long-term durability of nevirapine, efavirenz and lopinavir in routine clinical practice in Europe: a EuroSIDA study

18. History of viral suppression on combination antiretroviral therapy as a predictor of virological failure after a treatment change

19. Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study

20. Relationship between current level of immunodeficiency and non-acquired immunodeficiency syndrome-defining malignancies

21. Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe

22. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

23. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients

24. Dialysis and renal transplantation in HIV-infected patients: a European survey

25. Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

26. Does short-term virologic failure translate to clinical events in antiretroviral-naïve patients initiating antiretroviral therapy in clinical practice?

27. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

28. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

29. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

30. Importance of baseline prognostic factors with increasing time since initiation of highly active antiretroviral therapy: collaborative analysis of cohorts of HIV-1-infected patients

31. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe

33. Characteristics of Vilnius street prostitutes.

35. Are Specific Antiretrovirals associated with an Increased Risk of Discontinuation due to Toxicities or Patient/Physician Choice in patients with Hepatitis C Virus Coinfection?

36. Thymidine Analogue Mutation Profiles: Factors Associated with Acquiring Specific Profiles and their Impact on the Virological Response to Therapy

37. Baseline Resistance and Virological Outcome in Patients with Virological Failure who Start a Regimen Containing Abacavir: Eurosida Study

39. Incidence of tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America

40. Regional and temporal changes in AIDS in Europe before HAART

41. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

42. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.

43. HIV-1 genetic subtype A/B recombinant strain causing an explosive epidemic in injecting drug users in Kaliningrad.

44. [Studies of AIDS in Lithuania].

45. [The expert diagnosis of HIV infection by radioimmunoprecipitation].

46. [Risk of HIV infection in children with hemophilia].

47. [An analysis of blood sera by the immunoblot method using natural and recombinant antigens of the human immunodeficiency virus].

Catalog

Books, media, physical & digital resources